Sara Jane Ward - Publications

Affiliations: 
Temple University, Philadelphia, PA, United States 
Area:
Reinforcement, Addiction, Cannabinoids, Feeding

37 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Foss JD, Nayak SU, Tallarida CS, Farkas DJ, Ward SJ, Rawls SM. Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanism. Drug and Alcohol Dependence. 209: 107946. PMID 32145665 DOI: 10.1016/j.drugalcdep.2020.107946  0.48
2019 Reichenbach ZW, Stanek S, Patel S, Ward SJ, Malik Z, Parkman HP, Schey R. Botulinum Toxin A Improves Symptoms of Gastroparesis. Digestive Diseases and Sciences. PMID 31617132 DOI: 10.1007/s10620-019-05885-z  0.52
2018 Cotto B, Li H, Tuma RF, Ward SJ, Langford D. Cocaine-mediated activation of microglia and microglial MeCP2 and BDNF production. Neurobiology of Disease. PMID 29859319 DOI: 10.1016/j.nbd.2018.05.017  0.52
2018 Li H, Kong W, Chambers CR, Yu D, Ganea D, Tuma RF, Ward SJ. The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice. Cellular Immunology. PMID 29784129 DOI: 10.1016/j.cellimm.2018.02.016  0.52
2018 Myers AM, Siegele PB, Foss JD, Tuma RF, Ward SJ. Single and combined effects of plant-derived (THC, CBD) and synthetic (WIN-55,212) cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice. British Journal of Pharmacology. PMID 29338068 DOI: 10.1111/bph.14147  0.52
2017 Elliott MB, Ward SJ, Abood ME, Tuma RF, Jallo JI. Understanding the endocannabinoid system as a modulator of the trigeminal pain response to concussion. Concussion (London, England). 2: CNC49. PMID 30202590 DOI: 10.2217/cnc-2017-0010  0.52
2017 Ward SJ, Castelli F, Reichenbach ZW, Tuma RF. Surprising outcomes in cannabinoid CB1/CB2 receptor double knockout mice in two models of ischemia. Life Sciences. PMID 29288767 DOI: 10.1016/j.lfs.2017.12.030  0.52
2017 King KM, Myers AM, Soroka-Monzo AJ, Tuma RF, Tallarida RJ, Walker EA, Ward SJ. Single and combined effects of delta(9) -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain. British Journal of Pharmacology. PMID 28548225 DOI: 10.1111/bph.13887  0.96
2016 Neelakantan H, Ward SJ, Walker EA. Effects of paclitaxel on mechanical sensitivity and morphine reward in male and female C57Bl6 mice. Experimental and Clinical Psychopharmacology. 24: 485-495. PMID 27929349 DOI: 10.1037/pha0000097  0.96
2016 Reichenbach ZW, Li H, Ward SJ, Tuma RF. The CB1 Antagonist, SR141716A, Is Protective in Permanent Photothrombotic Cerebral Ischemia. Neuroscience Letters. PMID 27453059 DOI: 10.1016/j.neulet.2016.07.041  1
2015 Neelakantan H, Ward SJ, Walker EA. Discriminative stimulus effects of morphine and oxycodone in the absence and presence of acetic acid in male and female C57Bl/6 mice. Experimental and Clinical Psychopharmacology. 23: 217-27. PMID 26237319 DOI: 10.1037/pha0000028  0.96
2015 Ronca RD, Myers AM, Ganea D, Tuma RF, Walker EA, Ward SJ. A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice. Life Sciences. PMID 26032254 DOI: 10.1016/j.lfs.2015.05.005  1
2015 Neelakantan H, Tallarida RJ, Reichenbach ZW, Tuma RF, Ward SJ, Walker EA. Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice. Behavioural Pharmacology. 26: 304-14. PMID 25485642 DOI: 10.1097/FBP.0000000000000119  1
2015 Neelakantan H, Ward SJ, Walker EA. Discriminative stimulus effects of morphine and oxycodone in the absence and presence of acetic acid in male and female C57Bl/6 mice Experimental and Clinical Psychopharmacology. 23: 217-227. DOI: 10.1037/pha0000028  1
2014 Ward SJ, McAllister SD, Kawamura R, Murase R, Neelakantan H, Walker EA. Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy. British Journal of Pharmacology. 171: 636-45. PMID 24117398 DOI: 10.1111/bph.12439  1
2013 Ward SJ. Cancer, chemotherapy and cognition. Life Sciences. 93: 579-80. PMID 24095031 DOI: 10.1016/j.lfs.2013.09.021  1
2012 Raffa RB, Ward SJ. CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant). Journal of Clinical Pharmacy and Therapeutics. 37: 260-5. PMID 21740450 DOI: 10.1111/j.1365-2710.2011.01284.x  1
2012 Ward SJ. Cocaine effects are modulated by central CB 2 receptors in mice: New hope in a cannabinoid target for addiction and other CNS disorders Future Neurology. 7: 23-26. DOI: 10.2217/fnl.11.64  1
2011 Ward SJ, Ramirez MD, Neelakantan H, Walker EA. Cannabidiol prevents the development of cold and mechanical allodynia in paclitaxel-treated female C57Bl6 mice. Anesthesia and Analgesia. 113: 947-50. PMID 21737705 DOI: 10.1213/ANE.0b013e3182283486  1
2011 Ward SJ, Rasmussen BA, Corley G, Henry C, Kim JK, Walker EA, Rawls SM. Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 mice. Behavioural Pharmacology. 22: 370-3. PMID 21543969 DOI: 10.1097/FBP.0b013e3283473c10  1
2011 Rawls SM, Patil T, Tallarida CS, Baron S, Kim M, Song K, Ward S, Raffa RB. Nicotine behavioral pharmacology: clues from planarians. Drug and Alcohol Dependence. 118: 274-9. PMID 21530106 DOI: 10.1016/j.drugalcdep.2011.04.001  1
2011 Ward SJ, Raffa RB. Rimonabant redux and strategies to improve the future outlook of CB1 receptor neutral-antagonist/inverse-agonist therapies. Obesity (Silver Spring, Md.). 19: 1325-34. PMID 21475141 DOI: 10.1038/oby.2011.69  1
2010 Fischer BD, Ward SJ, Henry FE, Dykstra LA. Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects. Neuropharmacology. 58: 544-50. PMID 19699755 DOI: 10.1016/j.neuropharm.2009.08.005  1
2009 Ward SJ, Walker EA. Sex and cannabinoid CB1 genotype differentiate palatable food and cocaine self-administration behaviors in mice. Behavioural Pharmacology. 20: 605-13. PMID 19745722 DOI: 10.1097/FBP.0b013e328331ba30  1
2009 Ward SJ, Rosenberg M, Dykstra LA, Walker EA. The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse. Drug and Alcohol Dependence. 105: 248-55. PMID 19679410 DOI: 10.1016/j.drugalcdep.2009.07.002  1
2009 Ward SJ, Lefever TW, Rawls SM, Whiteside GT, Walker EA. Age-dependent effects of the cannabinoid CB1 antagonist SR141716A on food intake, body weight change, and pruritus in rats. Psychopharmacology. 206: 155-65. PMID 19575185 DOI: 10.1007/s00213-009-1592-6  1
2008 Miller LL, Ward SJ, Dykstra LA. Chronic unpredictable stress enhances cocaine-conditioned place preference in type 1 cannabinoid receptor knockout mice. Behavioural Pharmacology. 19: 575-81. PMID 18690112 DOI: 10.1097/FBP.0b013e32830ded11  1
2008 Ward SJ, Lefever TW, Jackson C, Tallarida RJ, Walker EA. Effects of a Cannabinoid1 receptor antagonist and Serotonin2C receptor agonist alone and in combination on motivation for palatable food: a dose-addition analysis study in mice. The Journal of Pharmacology and Experimental Therapeutics. 325: 567-76. PMID 18256173 DOI: 10.1124/jpet.107.131771  1
2008 Smith MA, Ward SJ, Roberts DC. Lesions of the dorsomedial frontal cortex block sensitization to the positive-reinforcing effects of cocaine. Pharmacology, Biochemistry, and Behavior. 88: 238-46. PMID 17904623 DOI: 10.1016/j.pbb.2007.08.007  1
2007 Ward SJ, Roberts DC. Microinjection of the delta-opioid receptor selective antagonist naltrindole 5'-isothiocyanate site specifically affects cocaine self-administration in rats responding under a progressive ratio schedule of reinforcement. Behavioural Brain Research. 182: 140-4. PMID 17572514 DOI: 10.1016/j.bbr.2007.05.003  1
2007 Xie S, Furjanic MA, Ferrara JJ, McAndrew NR, Ardino EL, Ngondara A, Bernstein Y, Thomas KJ, Kim E, Walker JM, Nagar S, Ward SJ, Raffa RB. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use. Journal of Clinical Pharmacy and Therapeutics. 32: 209-31. PMID 17489873 DOI: 10.1111/j.1365-2710.2007.00817.x  1
2007 Ward SJ, Walker EA, Dykstra LA. Effect of cannabinoid CB1 receptor antagonist SR141716A and CB1 receptor knockout on cue-induced reinstatement of Ensure and corn-oil seeking in mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2592-600. PMID 17392737 DOI: 10.1038/sj.npp.1301384  1
2006 Ward SJ, Läck C, Morgan D, Roberts DC. Discrete-trials heroin self-administration produces sensitization to the reinforcing effects of cocaine in rats. Psychopharmacology. 185: 150-9. PMID 16416157 DOI: 10.1007/s00213-005-0288-9  1
2005 Ward SJ, Dykstra LA. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940). Behavioural Pharmacology. 16: 381-8. PMID 16148442 DOI: 10.1097/00008877-200509000-00010  1
2005 Ward SJ, Morgan D, Roberts DC. Comparison of the reinforcing effects of cocaine and cocaine/heroin combinations under progressive ratio and choice schedules in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 286-95. PMID 15578009 DOI: 10.1038/sj.npp.1300560  1
2003 Ward SJ, Martin TJ, Roberts DC. Beta-funaltrexamine affects cocaine self-administration in rats responding on a progressive ratio schedule of reinforcement. Pharmacology, Biochemistry, and Behavior. 75: 301-7. PMID 12873620 DOI: 10.1016/S0091-3057(03)00087-X  1
1998 Aberman JE, Ward SJ, Salamone JD. Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance. Pharmacology, Biochemistry, and Behavior. 61: 341-8. PMID 9802826 DOI: 10.1016/S0091-3057(98)00112-9  1
Show low-probability matches.